Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Maarten Vink: the man and the surgeon.

The Netherlands journal of surgery

Zwaveling A.
PMID: 7029350
Neth J Surg. 1981 Oct;33(4):157-9.

No abstract available.

Cite
Zwaveling A. Maarten Vink: the man and the surgeon. Neth J Surg. 1981;33(4):157-9
Zwaveling, A. (1981). Maarten Vink: the man and the surgeon. The Netherlands journal of surgery, 33(4), 157-9.
Zwaveling, A. "Maarten Vink: the man and the surgeon." The Netherlands journal of surgery vol. 33,4 (1981): 157-9.
Zwaveling A. Maarten Vink: the man and the surgeon. Neth J Surg. 1981 Oct;33(4):157-9. PMID: 7029350.
Copy Download .nbib Format: NLM
Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy.

Frontiers in cardiovascular medicine

de Breet CPDM, Zwaveling S, Vries MJA, van Oerle RG, Henskens YMC, Van't Hof AWJ, van der Meijden PEJ, Veenstra L, Ten Cate H, Olie RH.
PMID: 34179143
Front Cardiovasc Med. 2021 Jun 10;8:679934. doi: 10.3389/fcvm.2021.679934. eCollection 2021.

No abstract available.

Cite
de Breet CPDM, Zwaveling S, Vries MJA, et al. Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy. Front Cardiovasc Med. 2021;8:679934doi: 10.3389/fcvm.2021.679934.
de Breet, C. P. D. M., Zwaveling, S., Vries, M. J. A., van Oerle, R. G., Henskens, Y. M. C., Van't Hof, A. W. J., van der Meijden, P. E. J., Veenstra, L., Ten Cate, H., & Olie, R. H. (2021). Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy. Frontiers in cardiovascular medicine, 8679934. https://doi.org/10.3389/fcvm.2021.679934
de Breet, C P D M, et al. "Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy." Frontiers in cardiovascular medicine vol. 8 (2021): 679934. doi: https://doi.org/10.3389/fcvm.2021.679934
de Breet CPDM, Zwaveling S, Vries MJA, van Oerle RG, Henskens YMC, Van't Hof AWJ, van der Meijden PEJ, Veenstra L, Ten Cate H, Olie RH. Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy. Front Cardiovasc Med. 2021 Jun 10;8:679934. doi: 10.3389/fcvm.2021.679934. eCollection 2021. PMID: 34179143; PMCID: PMC8224526.
Copy Download .nbib Format: NLM
Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool.

Scientific reports

van der Stoep MYEC, Berghuis D, Bredius RGM, Buddingh EP, Mohseny AB, Smiers FJW, Guchelaar HJ, Lankester AC, Zwaveling J.
PMID: 34580398
Sci Rep. 2021 Sep 27;11(1):19084. doi: 10.1038/s41598-021-98669-3.

Treosulfan is increasingly used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). In our pediatric HSCT program, myalgia was regularly observed after treosulfan-based conditioning, which is a relatively unknown side effect. Using a...

Cite
van der Stoep MYEC, Berghuis D, Bredius RGM, et al. Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool. Sci Rep. 2021;11(1):19084doi: 10.1038/s41598-021-98669-3.
van der Stoep, M. Y. E. C., Berghuis, D., Bredius, R. G. M., Buddingh, E. P., Mohseny, A. B., Smiers, F. J. W., Guchelaar, H. J., Lankester, A. C., & Zwaveling, J. (2021). Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool. Scientific reports, 11(1), 19084. https://doi.org/10.1038/s41598-021-98669-3
van der Stoep, M Y Eileen C, et al. "Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool." Scientific reports vol. 11,1 (2021): 19084. doi: https://doi.org/10.1038/s41598-021-98669-3
van der Stoep MYEC, Berghuis D, Bredius RGM, Buddingh EP, Mohseny AB, Smiers FJW, Guchelaar HJ, Lankester AC, Zwaveling J. Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool. Sci Rep. 2021 Sep 27;11(1):19084. doi: 10.1038/s41598-021-98669-3. PMID: 34580398; PMCID: PMC8476488.
Copy Download .nbib Format: NLM
Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review.

TH open : companion journal to thrombosis and haemostasis

Zwaveling S, Bloemen S, de Laat B, Ten Cate H, Ten Cate-Hoek A.
PMID: 31249953
TH Open. 2018 Sep 26;2(3):e291-e302. doi: 10.1055/s-0038-1672183. eCollection 2018 Jul.

No abstract available.

Cite
Zwaveling S, Bloemen S, de Laat B, et al. Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review. TH Open. 2018;2(3):e291-e302doi: 10.1055/s-0038-1672183.
Zwaveling, S., Bloemen, S., de Laat, B., Ten Cate, H., & Ten Cate-Hoek, A. (2018). Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review. TH open : companion journal to thrombosis and haemostasis, 2(3), e291-e302. https://doi.org/10.1055/s-0038-1672183
Zwaveling, Suzanne, et al. "Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review." TH open : companion journal to thrombosis and haemostasis vol. 2,3 (2018): e291-e302. doi: https://doi.org/10.1055/s-0038-1672183
Zwaveling S, Bloemen S, de Laat B, Ten Cate H, Ten Cate-Hoek A. Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review. TH Open. 2018 Sep 26;2(3):e291-e302. doi: 10.1055/s-0038-1672183. eCollection 2018 Jul. PMID: 31249953; PMCID: PMC6524885.
Copy Download .nbib Format: NLM
Changing concepts in cancer surgery.

Archivum chirurgicum Neerlandicum

VINK M, ZWAVELING A.
PMID: 13997371
Arch Chir Neerl. 1962;14:157-62.

No abstract available.

Cite
VINK M, ZWAVELING A. Changing concepts in cancer surgery. Arch Chir Neerl. 1962;14:157-62
VINK, M., & ZWAVELING, A. (1962). Changing concepts in cancer surgery. Archivum chirurgicum Neerlandicum, 14157-62.
VINK, M, and ZWAVELING, A. "Changing concepts in cancer surgery." Archivum chirurgicum Neerlandicum vol. 14 (1962): 157-62.
VINK M, ZWAVELING A. Changing concepts in cancer surgery. Arch Chir Neerl. 1962;14:157-62. PMID: 13997371.
Copy Download .nbib Format: NLM
[Histological diagnosis of malignant melanomas in children].

Nederlands tijdschrift voor geneeskunde

van der Heul RO, Blok AP, Zwaveling A, Westbroek DL.
PMID: 5914926
Ned Tijdschr Geneeskd. 1966 Jul 30;110(31):1376-80.

No abstract available.

Cite
van der Heul RO, Blok AP, Zwaveling A, et al. Histologische diagnostiek van maligne melanoom bij kinderen. [Histological diagnosis of malignant melanomas in children]. Ned Tijdschr Geneeskd. 1966;110(31):1376-80
van der Heul, R. O., Blok, A. P., Zwaveling, A., & Westbroek, D. L. (1966). Histologische diagnostiek van maligne melanoom bij kinderen. [Histological diagnosis of malignant melanomas in children]. Nederlands tijdschrift voor geneeskunde, 110(31), 1376-80.
van der Heul, R O, et al. "Histologische diagnostiek van maligne melanoom bij kinderen." [Histological diagnosis of malignant melanomas in children]. Nederlands tijdschrift voor geneeskunde vol. 110,31 (1966): 1376-80.
van der Heul RO, Blok AP, Zwaveling A, Westbroek DL. Histologische diagnostiek van maligne melanoom bij kinderen. [Histological diagnosis of malignant melanomas in children]. Ned Tijdschr Geneeskd. 1966 Jul 30;110(31):1376-80. Dutch. PMID: 5914926.
Copy Download .nbib Format: NLM
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study.

Transplantation and cellular therapy

van der Stoep MYEC, Bertaina A, Moes DJAR, Algeri M, Bredius RGM, Smiers FJW, Berghuis D, Buddingh EP, Mohseny AB, Guchelaar HJ, Locatelli F, Zwaveling J, Lankester AC.
PMID: 34607071
Transplant Cell Ther. 2021 Oct 01; doi: 10.1016/j.jtct.2021.09.018. Epub 2021 Oct 01.

Treosulfan-based conditioning has gained popularity in pediatric allogeneic hematopoietic stem cell transplantation (HSCT) because of its presumed favorable efficacy and toxicity profile. Treosulfan is used in standardized dosing regimens based on body surface area. The relationships between systemic treosulfan...

Cite
van der Stoep MYEC, Bertaina A, Moes DJAR, et al. Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study. Transplant Cell Ther. 2021;doi: 10.1016/j.jtct.2021.09.018.
van der Stoep, M. Y. E. C., Bertaina, A., Moes, D. J. A. R., Algeri, M., Bredius, R. G. M., Smiers, F. J. W., Berghuis, D., Buddingh, E. P., Mohseny, A. B., Guchelaar, H. J., Locatelli, F., Zwaveling, J., & Lankester, A. C. (2021). Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study. Transplantation and cellular therapy, . https://doi.org/10.1016/j.jtct.2021.09.018
van der Stoep, M Y Eileen C, et al. "Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study." Transplantation and cellular therapy vol. (2021). doi: https://doi.org/10.1016/j.jtct.2021.09.018
van der Stoep MYEC, Bertaina A, Moes DJAR, Algeri M, Bredius RGM, Smiers FJW, Berghuis D, Buddingh EP, Mohseny AB, Guchelaar HJ, Locatelli F, Zwaveling J, Lankester AC. Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study. Transplant Cell Ther. 2021 Oct 01; doi: 10.1016/j.jtct.2021.09.018. Epub 2021 Oct 01. PMID: 34607071.
Copy Download .nbib Format: NLM
A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation.

TH open : companion journal to thrombosis and haemostasis

Kicken CH, van der Vorm LN, Zwaveling S, Schoenmaker E, Remijn JA, Huskens D, de Laat B.
PMID: 31338487
TH Open. 2019 Jul 22;3(3):e216-e226. doi: 10.1055/s-0039-1692991. eCollection 2019 Jul.

No abstract available.

Cite
Kicken CH, van der Vorm LN, Zwaveling S, et al. A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation. TH Open. 2019;3(3):e216-e226doi: 10.1055/s-0039-1692991.
Kicken, C. H., van der Vorm, L. N., Zwaveling, S., Schoenmaker, E., Remijn, J. A., Huskens, D., & de Laat, B. (2019). A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation. TH open : companion journal to thrombosis and haemostasis, 3(3), e216-e226. https://doi.org/10.1055/s-0039-1692991
Kicken, Cécile H, et al. "A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation." TH open : companion journal to thrombosis and haemostasis vol. 3,3 (2019): e216-e226. doi: https://doi.org/10.1055/s-0039-1692991
Kicken CH, van der Vorm LN, Zwaveling S, Schoenmaker E, Remijn JA, Huskens D, de Laat B. A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation. TH Open. 2019 Jul 22;3(3):e216-e226. doi: 10.1055/s-0039-1692991. eCollection 2019 Jul. PMID: 31338487; PMCID: PMC6645913.
Copy Download .nbib Format: NLM
No need for H.

British journal of cancer

Gelderblom H, Zwaveling J.
PMID: 33762719
Br J Cancer. 2021 May;124(10):1613-1614. doi: 10.1038/s41416-021-01316-x. Epub 2021 Mar 24.

The theoretical basis for use of histamine 2 (H

Cite
Gelderblom H, Zwaveling J. No need for H. Br J Cancer. 2021;124(10):1613-1614doi: 10.1038/s41416-021-01316-x.
Gelderblom, H., & Zwaveling, J. (2021). No need for H. British journal of cancer, 124(10), 1613-1614. https://doi.org/10.1038/s41416-021-01316-x
Gelderblom, Hans, and Zwaveling, Juliette. "No need for H." British journal of cancer vol. 124,10 (2021): 1613-1614. doi: https://doi.org/10.1038/s41416-021-01316-x
Gelderblom H, Zwaveling J. No need for H. Br J Cancer. 2021 May;124(10):1613-1614. doi: 10.1038/s41416-021-01316-x. Epub 2021 Mar 24. PMID: 33762719; PMCID: PMC7987749.
Copy Download .nbib Format: NLM
No need for H.

British journal of cancer

Gelderblom H, Zwaveling J.
PMID: 33762719
Br J Cancer. 2021 May;124(10):1613-1614. doi: 10.1038/s41416-021-01316-x. Epub 2021 Mar 24.

The theoretical basis for use of histamine 2 (H

Cite
Gelderblom H, Zwaveling J. No need for H. Br J Cancer. 2021;124(10):1613-1614doi: 10.1038/s41416-021-01316-x.
Gelderblom, H., & Zwaveling, J. (2021). No need for H. British journal of cancer, 124(10), 1613-1614. https://doi.org/10.1038/s41416-021-01316-x
Gelderblom, Hans, and Zwaveling, Juliette. "No need for H." British journal of cancer vol. 124,10 (2021): 1613-1614. doi: https://doi.org/10.1038/s41416-021-01316-x
Gelderblom H, Zwaveling J. No need for H. Br J Cancer. 2021 May;124(10):1613-1614. doi: 10.1038/s41416-021-01316-x. Epub 2021 Mar 24. PMID: 33762719; PMCID: PMC7987749.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries